Codes / ICD10CM / A17.9

A17.9 Tuberculosis of nervous system, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Tuberculosis of nervous system, unspecified

Summary

Tuberculosis of the nervous system, unspecified, is a form of extrapulmonary tuberculosis (TB) affecting the central nervous system, including the brain, spinal cord, or meninges, where the specific site or type of involvement is not further defined. It occurs when Mycobacterium tuberculosis bacteria spread to these areas, leading to inflammation and potential neurological complications. Prompt diagnosis and treatment are critical to prevent severe outcomes.

Causes

Tuberculosis of the nervous system, unspecified, is caused by the spread of Mycobacterium tuberculosis from a primary TB infection, typically in the lungs, to the central nervous system. The bacteria can reach the nervous system through the bloodstream or by direct extension from adjacent infected tissues.

Risk Factors

  • Active pulmonary tuberculosis or other extrapulmonary TB
  • Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
  • Malnutrition or chronic illness
  • Recent TB exposure or infection
  • Lack of access to TB treatment or preventive care

Symptoms

  • Persistent headache
  • Fever and night sweats
  • Stiff neck (meningitis)
  • Nausea and vomiting
  • Neurological deficits (e.g., weakness, numbness, confusion)
  • Seizures
  • Changes in mental status

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., MRI or CT scans), and laboratory testing. Cerebrospinal fluid (CSF) analysis is critical to detect TB bacteria, inflammatory markers, or other abnormalities. Biopsy may be performed if a specific lesion is identified.

Treatment Options

Treatment typically includes a prolonged course of multiple anti-TB medications, such as isoniazid, rifampin, pyrazinamide, and ethambutol, often extended to 9–12 months. Corticosteroids may be used to reduce inflammation, especially in cases of meningitis. Close monitoring for drug resistance and side effects is essential.

Prognosis and Follow-Up

Prognosis depends on early diagnosis, treatment adherence, and the extent of neurological damage. Follow-up includes regular clinical assessments, imaging, and laboratory tests to monitor treatment response and detect complications. Long-term neurological sequelae may occur in some cases.

Complications

  • Permanent neurological deficits (e.g., paralysis, cognitive impairment)
  • Hydrocephalus
  • Stroke or cerebral edema
  • Drug-resistant TB
  • Recurrence of infection

Lifestyle & Prevention

  • Complete the full course of prescribed TB medications to prevent resistance.
  • Maintain good nutrition and overall health to support immune function.
  • Avoid exposure to individuals with active TB, especially in high-risk settings.
  • Follow public health guidelines for TB screening and prevention, particularly for those with weakened immunity.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, stiff neck, confusion, seizures, or sudden neurological changes, as these may indicate a serious infection requiring urgent care.

Tips for Medical Coders

Use code A17.9 for tuberculosis of the nervous system when the specific site or type of involvement is not documented. Ensure documentation supports the diagnosis and excludes more specific codes (e.g., tuberculous meningitis or tuberculoma) if applicable. Verify that the condition is confirmed by clinical or laboratory findings.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

A17.9 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.